MedPath

Mefloquine Hydrochloride

Mefloquine Hydrochloride Tablets, USP

Approved
Approval ID

43fde257-36ee-49ea-a03c-01a1a4e1da3d

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 15, 2021

Manufacturers
FDA

Hikma Pharmaceuticals USA Inc.

DUNS: 080189610

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

mefloquine hydrochloride

PRODUCT DETAILS

NDC Product Code0054-0025
Application NumberANDA076523
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateJanuary 14, 2021
Generic Namemefloquine hydrochloride

INGREDIENTS (11)

MEFLOQUINE HYDROCHLORIDEActive
Quantity: 250 mg in 1 1
Code: 5Y9L3636O3
Classification: ACTIB
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
PROPYLENE GLYCOL ALGINATEInactive
Code: 26CD3J2R0C
Classification: IACT
CROSPOVIDONE (15 MPA.S AT 5%)Inactive
Code: 68401960MK
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
CALCIUM ALGINATEInactive
Code: 8P20S56HZI
Classification: IACT
POLOXAMER 331Inactive
Code: IS93EQR73R
Classification: IACT
POVIDONE K30Inactive
Code: U725QWY32X
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Mefloquine Hydrochloride - FDA Drug Approval Details